Literature DB >> 27132573

Hypogonadism: Its Prevalence and Diagnosis.

Anna Ross1, Shalender Bhasin2.   

Abstract

Hypogonadism is a clinical syndrome, which results from the failure of the testes to produce physiologic levels of testosterone and a normal number of spermatozoa due to defects at one or more levels of the hypothalamic-pituitary-gonadal axis. Primary hypogonadism results from malfunction at the level of the testes due to a genetic cause, injury, inflammation, or infection. Hypothalamic and/or pituitary failure leads to secondary hypogonadism, most often as a result of genetic defects, neoplasm, or infiltrative disorders. The signs and symptoms of hypogonadism depend on the age of onset, severity of androgen deficiency, and underlying cause of androgen deficiency.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgen deficiency; Diagnosis; Hypogonadism; Prevalence

Mesh:

Substances:

Year:  2016        PMID: 27132573     DOI: 10.1016/j.ucl.2016.01.002

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  11 in total

Review 1.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

2.  Trends and Patterns of Testosterone Therapy among U.S. Male Medicare Beneficiaries, 1999 to 2014.

Authors:  Cindy Ke Zhou; Shailesh Advani; Matthew Chaloux; James Todd Gibson; Mandi Yu; Marie Bradley; Robert N Hoover; Michael B Cook
Journal:  J Urol       Date:  2020-01-13       Impact factor: 7.450

Review 3.  Paediatric and adult-onset male hypogonadism.

Authors:  Andrea Salonia; Giulia Rastrelli; Geoffrey Hackett; Stephanie B Seminara; Ilpo T Huhtaniemi; Rodolfo A Rey; Wayne J G Hellstrom; Mark R Palmert; Giovanni Corona; Gert R Dohle; Mohit Khera; Yee-Ming Chan; Mario Maggi
Journal:  Nat Rev Dis Primers       Date:  2019-05-30       Impact factor: 52.329

4.  An Indonesian male with congenital hypogonadotropic hypogonadism: A case report and literature review.

Authors:  Leadri Surya Arrosy; Hermina Novida
Journal:  Ann Med Surg (Lond)       Date:  2022-09-15

Review 5.  Movement Disorders Associated with Hypogonadism.

Authors:  Paulina Gonzalez-Latapi; Mario Sousa; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2021-07-29

6.  The clinical and psychological profiles of patients with hypogonadism, followed in 3 reference hospitals of Cameroon: an observational study.

Authors:  Martine Claude Etoa Etoga; Gilbert Akwa; Anne Ongmeb Boli; Ahmadou Musa Jingi; Jean-Claude Njabou Katte; Nelly Sandra Ndam Ngambou; Brigitte Wandji; Mesmin Dehayem; Jean Claude Mbanya; Simeon-Pierre Choukem; Eugene Sobngwi
Journal:  Pan Afr Med J       Date:  2019-05-22

7.  Barriers to receiving testosterone replacement therapy in the community during COVID-19 pandemic.

Authors:  Victoria L Troesch; Denise Juhr; Amy Pearlman
Journal:  Transl Androl Urol       Date:  2021-08

8.  Hyperprolactinemia and Hypopituitarism in Acromegaly and Effect of Pituitary Surgery: Long-Term Follow-up on 529 Patients.

Authors:  Xiaopeng Guo; Ruopeng Zhang; Duoxing Zhang; Zihao Wang; Lu Gao; Yong Yao; Kan Deng; Xinjie Bao; Ming Feng; Zhiqin Xu; Yi Yang; Wei Lian; Renzhi Wang; Wenbin Ma; Bing Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-26       Impact factor: 5.555

9.  Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses.

Authors:  Helena Florez; Jose Hernández-Rodríguez; Josep Lluis Carrasco; Sergio Prieto-González; Africa Muxi; Xavier Filella; Silvia Ruiz-Gaspà; José A Gómez-Puerta; Maria Cid; Gerard Espinosa; Ana Monegal; Núria Guañabens; Pilar Peris
Journal:  RMD Open       Date:  2020-09

10.  Hypogonadism and liver fibrosis in HIV-infected patients.

Authors:  E Quiros-Roldan; T Porcelli; L C Pezzaioli; M Degli Antoni; S Paghera; M Properzi; E Focà; C Carriero; F Castelli; A Ferlin
Journal:  J Endocrinol Invest       Date:  2021-01-29       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.